• S1E3 - SGLT-2 Inhibitors Morning Commute: Optimizing Benefit in CKD Management

  • Feb 27 2021
  • Length: 25 mins
  • Podcast
S1E3 - SGLT-2 Inhibitors Morning Commute: Optimizing Benefit in CKD Management By cover art

S1E3 - SGLT-2 Inhibitors Morning Commute: Optimizing Benefit in CKD Management

Listen for free

View show details

  • Summary

  • Visit http://morningcommutepodcast.com/SGLT2inhibitors3 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this episode, our experts will focus on chronic kidney disease (CKD) in patients with or without diabetes and treatment with sodium-glucose cotransporter 2 (SGLT-2) inhibitors. The bottom line is, how should these treatments be incorporated into clinical practice?
    Show more Show less
Show more Show less

What listeners say about S1E3 - SGLT-2 Inhibitors Morning Commute: Optimizing Benefit in CKD Management

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available